128 related articles for article (PubMed ID: 9851782)
1. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors.
Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782
[TBL] [Abstract][Full Text] [Related]
2. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
3. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas.
Lania A; Persani L; Ballaré E; Mantovani S; Losa M; Spada A
J Clin Endocrinol Metab; 1998 May; 83(5):1624-8. PubMed ID: 9589667
[TBL] [Abstract][Full Text] [Related]
4. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
[TBL] [Abstract][Full Text] [Related]
6. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
7. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
[TBL] [Abstract][Full Text] [Related]
10. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
11. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
Barlier A; Gunz G; Zamora AJ; Morange-Ramos I; Figarella-Branger D; Dufour H; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.
Harris PE; Alexander JM; Bikkal HA; Hsu DW; Hedley-Whyte ET; Klibanski A; Jameson JL
J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
Landis CA; Harsh G; Lyons J; Davis RL; McCormick F; Bourne HR
J Clin Endocrinol Metab; 1990 Dec; 71(6):1416-20. PubMed ID: 2121775
[TBL] [Abstract][Full Text] [Related]
15. A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours.
Clementi E; Malgaretti N; Meldolesi J; Taramelli R
Oncogene; 1990 Jul; 5(7):1059-61. PubMed ID: 2115641
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.
Lania A; Mantovani G; Ferrante E; Zavanone LM; Locatelli M; Corbetta S; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2004 Apr; 27(4):328-33. PubMed ID: 15233551
[TBL] [Abstract][Full Text] [Related]
17. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M
Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229
[TBL] [Abstract][Full Text] [Related]
18. Gs protein mutations and the pathogenesis and function of pituitary tumors.
Harris PE
Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
[TBL] [Abstract][Full Text] [Related]
19. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E
J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579
[TBL] [Abstract][Full Text] [Related]
20. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
